247 related articles for article (PubMed ID: 22032327)
1. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.
Tang HY; Beer LA; Chang-Wong T; Hammond R; Gimotty P; Coukos G; Speicher DW
J Proteome Res; 2012 Feb; 11(2):678-91. PubMed ID: 22032327
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera.
Beer LA; Wang H; Tang HY; Cao Z; Chang-Wong T; Tanyi JL; Zhang R; Liu Q; Speicher DW
PLoS One; 2013; 8(3):e60129. PubMed ID: 23544127
[TBL] [Abstract][Full Text] [Related]
3. Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.
Tang HY; Beer LA; Tanyi JL; Zhang R; Liu Q; Speicher DW
J Proteomics; 2013 Aug; 89():165-78. PubMed ID: 23792823
[TBL] [Abstract][Full Text] [Related]
4. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
[TBL] [Abstract][Full Text] [Related]
5. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
[TBL] [Abstract][Full Text] [Related]
6. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation.
Beer LA; Tang HY; Sriswasdi S; Barnhart KT; Speicher DW
J Proteome Res; 2011 Mar; 10(3):1126-38. PubMed ID: 21142075
[TBL] [Abstract][Full Text] [Related]
7. Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human.
Juan HF; Chen JH; Hsu WT; Huang SC; Chen ST; Yi-Chung Lin J; Chang YW; Chiang CY; Wen LL; Chan DC; Liu YC; Chen YJ
Proteomics; 2004 Sep; 4(9):2766-75. PubMed ID: 15352250
[TBL] [Abstract][Full Text] [Related]
8. Proteomics analysis for finding serum markers of ovarian cancer.
Cheng Y; Liu C; Zhang N; Wang S; Zhang Z
Biomed Res Int; 2014; 2014():179040. PubMed ID: 25250314
[TBL] [Abstract][Full Text] [Related]
9. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.
Pitteri SJ; JeBailey L; Faça VM; Thorpe JD; Silva MA; Ireton RC; Horton MB; Wang H; Pruitt LC; Zhang Q; Cheng KH; Urban N; Hanash SM; Dinulescu DM
PLoS One; 2009 Nov; 4(11):e7916. PubMed ID: 19936259
[TBL] [Abstract][Full Text] [Related]
10. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.
Goufman EI; Moshkovskii SA; Tikhonova OV; Lokhov PG; Zgoda VG; Serebryakova MV; Toropygin IY; Vlasova MA; Safarova MR; Makarov OV; Archakov AI
Biochemistry (Mosc); 2006 Apr; 71(4):354-60. PubMed ID: 16615854
[TBL] [Abstract][Full Text] [Related]
12. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
Timms JF; Arslan-Low E; Kabir M; Worthington J; Camuzeaux S; Sinclair J; Szaub J; Afrough B; Podust VN; Fourkala EO; Cubizolles M; Kronenberg F; Fung ET; Gentry-Maharaj A; Menon U; Jacobs I
Proteomics Clin Appl; 2014 Dec; 8(11-12):982-93. PubMed ID: 25290619
[TBL] [Abstract][Full Text] [Related]
13. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
15. High-resolution serum proteomic features for ovarian cancer detection.
Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
[TBL] [Abstract][Full Text] [Related]
16. A targeted proteomics-based pipeline for verification of biomarkers in plasma.
Whiteaker JR; Lin C; Kennedy J; Hou L; Trute M; Sokal I; Yan P; Schoenherr RM; Zhao L; Voytovich UJ; Kelly-Spratt KS; Krasnoselsky A; Gafken PR; Hogan JM; Jones LA; Wang P; Amon L; Chodosh LA; Nelson PS; McIntosh MW; Kemp CJ; Paulovich AG
Nat Biotechnol; 2011 Jun; 29(7):625-34. PubMed ID: 21685906
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
Stevens EV; Liotta LA; Kohn EC
Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
[TBL] [Abstract][Full Text] [Related]
19. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
